Skip to main content
Clinical Trials/NCT00966121
NCT00966121UnknownPhase 4

RCT Comparing the Efficacies of Endoscopic Variceal Ligation (EBL) and Combined Treatment of Beta-blocker and EBL for the Prevention of Esophageal Variceal Rebleeding

Korea University2 sites in 1 country180 target enrollmentStarted: August 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Enrollment
180
Locations
2
Primary Endpoint
Rebleeding from esophageal varices

Study Overview

Brief Summary

Both propranolol and endoscopic band ligation (EBL) are effective for prevention of variceal rebleeding. Recently several studies compared the efficacy of EBL alone and with a combination of propranolol and EBL. However, the results of recent studies showed discrepancy. This study is performed to compare the efficacy and safety of EBL alone and EBL combined with propranolol in patients without previous history of endoscopic variceal treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • liver cirrhosis
  • age between 18 and 70 years
  • Successful control of esophageal variceal bleeding within 6 weeks before enrollment

Exclusion Criteria

  • Gastric variceal bleeding
  • Patients with systolic blood pressure <100 mmHg or basal heart rate <60/min
  • Portal vein thrombosis
  • Prominent hepatic encephalopathy
  • Coexisting untreated malignancy
  • Severe cerebrovascular or cardiovascular disease, renal failure
  • Previous history of endoscopic, radiologic, or surgical treatment for varices or ascites
  • Contraindication to beta-blocker
  • Pregnancy
  • Refusal to give consent to participate in the trial

Arms & Interventions

Endoscopic band ligation

Active Comparator

Perform endoscopic band ligation (EBL) until esophageal varices are eradicated, and then follow-up endoscopy with 3-6 months interval

Intervention: endoscopic band ligation (Procedure)

EBL+Propranolol

Active Comparator

Perform EBL same as EBL group. In addition, take propranolol to reduce 25% in HR or HR ≤55/min

Intervention: EBL+Propranolol (Procedure)

Outcomes

Primary Outcomes

Rebleeding from esophageal varices

Time Frame: 2 years

Rebleeding from esophageal varices

Secondary Outcomes

  • Upper gastrointestinal bleeding; significant esophageal variceal bleeding; mortality;adverse events(2 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Soon Ho Um

Professor

Korea University

Study Sites (2)

Loading locations...

Similar Trials

Endoscopic Band Ligation (EBL) Versus... | Clinical Trial